Dr D Y Patil Institute of Pharmaceutical Sciences and Research, Pune
Also known as School of Pharmacy and Research, DPGU
- Fees / year
- ₹1L - ₹3.3L
- Courses
- 7+
- Median salary
- ₹3.45 LPA
- Placed
- 48.3%
- NIRF Pharmacy
- #35
- Established
- 1994
Dr D Y Patil Institute of Pharmaceutical Sciences and Research, Pune: Frequently Asked Questions
What is the NIRF ranking of Dr D Y Patil Institute of Pharmaceutical Sciences and Research, Pune?
In the NIRF 2025 rankings, Dr D Y Patil Institute of Pharmaceutical Sciences and Research, Pune is ranked #35 in Pharmacy.
How are placements at Dr D Y Patil Institute of Pharmaceutical Sciences and Research, Pune?
In the data Dr D Y Patil Institute of Pharmaceutical Sciences and Research, Pune submitted to NIRF 2025, 57 of the 118 students who graduated from its 4-year UG programmes in 2023–24 were placed (48.3%), at a median salary of ₹3.45 LPA. Another 57 went on to higher studies.
What is the fee at Dr D Y Patil Institute of Pharmaceutical Sciences and Research, Pune?
First-year tuition at Dr D Y Patil Institute of Pharmaceutical Sciences and Research, Pune is ₹2,50,000 (Bachelor of Pharmacy - General) to ₹2,75,000 (Doctor of Pharmacy - General) for undergraduate programmes and ₹1,00,000 (Master of Science - Pharmaceutical Analysis) to ₹3,30,000 (Master of Pharmacy - Pharmaceutical Quality Assurance) for postgraduate programmes. Fees are per year and may change for new batches; confirm with the college before paying.
Which courses does Dr D Y Patil Institute of Pharmaceutical Sciences and Research, Pune offer?
Dr D Y Patil Institute of Pharmaceutical Sciences and Research, Pune offers 7 programmes in Science and Pharmacy, including Master of Science, Bachelor of Pharmacy, Doctor of Pharmacy, Diploma in Pharmacy and Master of Pharmacy.
Which entrance exams does Dr D Y Patil Institute of Pharmaceutical Sciences and Research, Pune accept?
Depending on the course, admission to Dr D Y Patil Institute of Pharmaceutical Sciences and Research, Pune is through MHT-CET and NEET-UG.
What is the admission process at Dr D Y Patil Institute of Pharmaceutical Sciences and Research, Pune?
B.Pharm and B.Pharm + MBA admission is based on DPGU's own entrance test (DPAT), with candidates holding a non-zero MHT-CET, NEET or other state/national pharmacy entrance score exempted from DPAT; M.Pharm admission is by a personal interview conducted by the university, with preference for candidates with a non-zero GPAT score.
Is Dr D Y Patil Institute of Pharmaceutical Sciences and Research, Pune a government or private institution?
Dr D Y Patil Institute of Pharmaceutical Sciences and Research, Pune is a private institution in Pune, Maharashtra, established in 1994. It is affiliated to Constituent unit of Dnyaan Prasad Global University.
Which bodies approve or accredit Dr D Y Patil Institute of Pharmaceutical Sciences and Research, Pune?
Dr D Y Patil Institute of Pharmaceutical Sciences and Research, Pune lists approval or accreditation from PCI, NAAC and UGC.
Do students at Dr D Y Patil Institute of Pharmaceutical Sciences and Research, Pune get scholarships or fee waivers?
In 2023–24, 429 of its 813 students had their full tuition fee reimbursed: 395 through state and central government schemes and 34 by private bodies (NIRF 2025 data).
How many students study at Dr D Y Patil Institute of Pharmaceutical Sciences and Research, Pune?
813 students were enrolled across its programmes in 2023–24, 53.5% of them women (NIRF 2025 data).
What other names is Dr D Y Patil Institute of Pharmaceutical Sciences and Research, Pune known by?
Dr D Y Patil Institute of Pharmaceutical Sciences and Research, Pune is also known as School of Pharmacy and Research, DPGU.
Sources
Rankings: NIRF India Rankings 2025, Ministry of Education. Placement, student and fee-reimbursement figures: data submitted by the institution to NIRF 2025.
Courses and fees: as listed for Dr D Y Patil Institute of Pharmaceutical Sciences and Research, Pune on CollegeChalo; confirm current fees with the college before applying.
Last updated 9 November 2026.